Literature DB >> 17334720

Successful treatment of advanced gastric cancer by surgical resection following combination chemotherapy with oral S-1 and biweekly paclitaxel.

Akihiro Nakajo1, Shoji Natsugoe, Shuichi Hokita, Sumiya Ishigami, Hiroyuki Takatori, Takaaki Arigami, Yoshikazu Uenosono, Kuniaki Aridome, Takashi Aikou.   

Abstract

We report on the successful treatment of advanced gastric cancer by surgical resection following neoadjuvant chemotherapy. A 67-year-old man was referred to our hospital with a diagnosis of pancreatic cancer. Meticulous examination, however, revealed the presence of gastric cancer with ascites and large lymph node metastasis adjacent to the pancreas. We selected combination chemotherapy with oral S-1 and biweekly paclitaxel. After two courses, both the primary tumor and metastatic lymph nodes were greatly reduced, and the ascites had disappeared. Using laparoscopy, there was no evidence of peritoneal metastases, and the cytological examination was negative. The patient underwent distal gastrectomy with D2 lymph node dissection. Histological examination revealed that the cancer cells were still present in part, but no lymph node metastases were found. The tumor was pathologically diagnosed as pT2, pN0, P0, M0, CY0, and p-stage II. The patient is healthy over 4 years after surgery without recurrence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17334720     DOI: 10.1007/s10120-006-0394-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  17 in total

1.  Advanced gastric cancer with liver metastases successfully treated with S-1.

Authors:  Shin Watanabe; Takashi Tanaka; Tadayuki Takeuchi; Hiroshi Takabayashi; Yoji Hirayama
Journal:  Int J Clin Oncol       Date:  2002-10       Impact factor: 3.402

2.  A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen.

Authors:  Yasuhiro Sato; Hitoshi Kondo; Kana Honda; Daisuke Takahari; Tetsuya Sumiyoshi; Yasushi Tsuji; Naohito Yoshizaki; Yoshiro Niitsu
Journal:  Int J Clin Oncol       Date:  2005-02       Impact factor: 3.402

3.  Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case.

Authors:  M Iwahashi; M Nakamori; M Tani; H Yamaue; S Sakaguchi; M Nakamura; K Ueda; M Ichiro; E Nishino; H Tanimura
Journal:  Oncology       Date:  2001       Impact factor: 2.935

Review 4.  Chemotherapy of gastric cancer.

Authors:  D L Schipper; D J Wagener
Journal:  Anticancer Drugs       Date:  1996-02       Impact factor: 2.248

5.  Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators.

Authors:  T Shirasaka; Y Shimamato; H Ohshimo; M Yamaguchi; T Kato; K Yonekura; M Fukushima
Journal:  Anticancer Drugs       Date:  1996-07       Impact factor: 2.248

6.  Japanese Classification of Gastric Carcinoma - 2nd English Edition -

Authors: 
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

7.  A randomized phase II clinical trial of tailored CPT-11 + S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy.

Authors:  Yutaka Takahashi; Junichi Sakamoto; Tetsuo Takeuchi; Masayoshi Mai; Tetsuro Kubota; Masaki Kitajima; Yusuke Tanigawara; Yoshito Komatsu; Tetsuya Toge; Shigetoyo Saji
Journal:  Jpn J Clin Oncol       Date:  2004-06       Impact factor: 3.019

8.  Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.

Authors:  Shunichi Tsujitani; Kenji Fukuda; Nobuaki Kaibara
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

9.  Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.

Authors:  Hideo Baba; Manabu Yamamoto; Kazuya Endo; Yasuharu Ikeda; Yasushi Toh; Shunji Kohnoe; Takeshi Okamura
Journal:  Gastric Cancer       Date:  2003       Impact factor: 7.370

10.  Clinical and pathological disappearance of peritoneal dissemination in a patient with advanced gastric cancer receiving chemotherapy with S-1 and low-dose cisplatin.

Authors:  Yukako Akatsu; Yoshiro Saikawa; Tetsuro Kubota; Masashi Yoshida; Toshiharu Furukawa; Yoshihide Otani; Koichiro Kumai; Masaki Kitajima
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

View more
  3 in total

Review 1.  Paclitaxel chemotherapy for the treatment of gastric cancer.

Authors:  Junichi Sakamoto; Takanori Matsui; Yasuhiro Kodera
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

2.  The number of metastatic lymph nodes is a significant risk factor for bone metastasis and poor outcome after surgery for linitis plastica-type gastric carcinoma.

Authors:  Yasuhiro Kodera; Seiji Ito; Yoshinari Mochizuki; Yoshitaka Yamamura; Kazunari Misawa; Norifumi Ohashi; Goro Nakayama; Masahiko Koike; Michitaka Fujiwara; Akimasa Nakao
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

3.  TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway.

Authors:  Shekoufeh Almasi; Barry E Kennedy; Mariam El-Aghil; Andra M Sterea; Shashi Gujar; Santiago Partida-Sánchez; Yassine El Hiani
Journal:  J Biol Chem       Date:  2018-01-17       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.